Goldman Sachs’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-27,628
| Closed | -$658K | – | 5761 |
|
|
2021
Q4 | $658K | Buy |
+27,628
| New | +$658K | ﹤0.01% | 4340 |
|
|
2021
Q2 | – | Sell |
-19,944
| Closed | -$597K | – | 5376 |
|
|
2021
Q1 | $597K | Buy |
19,944
+2,334
| +13% | +$69.9K | ﹤0.01% | 4238 |
|
|
2020
Q4 | $559K | Hold |
17,610
| – | – | ﹤0.01% | 3765 |
|
|
2020
Q3 | $484K | Hold |
17,610
| – | – | ﹤0.01% | 3685 |
|
|
2020
Q2 | $477K | Hold |
17,610
| – | – | ﹤0.01% | 3619 |
|
|
2020
Q1 | $344K | Hold |
17,610
| – | – | ﹤0.01% | 3679 |
|
|
2019
Q4 | $413K | Buy |
+17,610
| New | +$413K | ﹤0.01% | 3739 |
|